GABAB receptor modulation-to B or not to be B a pro-cognitive medicine?

Abstract:

:Metabotropic GABAB receptors clearly modify cognitive performance in preclinical animal models, yet translation to treating human disease has been elusive. Compared to their ionotropic GABAA receptor counterpart GABAB receptors not only regulate postsynaptic excitability but also regulate diverse synaptic inputs by presynaptically inhibiting neurotransmitter release. As such, the choice of agonist, antagonist, -ve or +ve modulator as well as CNS exposure level, timing of delivery and longevity of action strongly influence the probability of unlocking the procognitive potential of GABAB receptors in human disease. Quantitative clinical analysis of target/mechanistic engagement of GABAB receptors within cognitive circuits at the level of distinct pre-synaptic and post-synaptic subpopulations is required to determine the optimal pharmacological/dosing profile for different cognitive disorders.

journal_name

Curr Opin Pharmacol

authors

Serrats J,Cunningham MO,Davies CH

doi

10.1016/j.coph.2017.09.012

subject

Has Abstract

pub_date

2017-08-01 00:00:00

pages

125-132

eissn

1471-4892

issn

1471-4973

pii

S1471-4892(17)30114-5

journal_volume

35

pub_type

杂志文章,评审
  • Epidermal growth factor receptor tyrosine kinase inhibitors.

    abstract::Clinical trials of selective small-molecule inhibitors of epidermal growth factor receptor tyrosine kinase activity have shown that these targeted inhibitors of proliferative signal transduction provide well-tolerated antitumour activity in patients. Preclinical pharmacology studies illustrate the potential use of the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00183-2

    authors: Wakeling AE

    更新日期:2002-08-01 00:00:00

  • Determinants of chemosensitivity in gastric cancer.

    abstract::Recent advances in the management of gastric cancer, especially in the arena of chemotherapy, are paving the way for optimization of treatment that maximizes effectiveness while minimizing toxicity. The expansion of the chemotherapeutic armamentarium has led to multiple combinations of cytotoxic agents. Unfortunately,...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.05.002

    authors: Park DJ,Lenz HJ

    更新日期:2006-08-01 00:00:00

  • Psychological side effects of immune therapies: symptoms and pathomechanism.

    abstract::Immunotherapies revolutionised the treatment of several disorders but show specific side-effect profiles which frequently involve psychological symptoms. Long term interferon-alpha (IFN-alpha) therapy can cause wide-ranging psychiatric side-effects from fatigue, insomnia, anxiety to full-blown depression. This treatme...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.06.008

    authors: Kovacs D,Kovacs P,Eszlari N,Gonda X,Juhasz G

    更新日期:2016-08-01 00:00:00

  • 5-HT(6) receptor and cognition.

    abstract::Since its discovery in 1993 and subsequent development of selective antagonists, a growing number of studies support the use of serotonin 5-HT(6) receptor antagonism as a promising mechanism for treating cognitive dysfunction. Lately, several studies with structurally different compounds have shown that not only antag...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.01.004

    authors: Codony X,Vela JM,Ramírez MJ

    更新日期:2011-02-01 00:00:00

  • Drugs acting on SUR1 to treat CNS ischemia and trauma.

    abstract::Sulfonylurea receptor 1 (SUR1) is a molecule with more diverse and critically important functions than previously recognized. Long viewed simply as a subunit involved in formation of a subset of K(ATP) channels, accumulating evidence indicates that SUR1 is newly upregulated in CNS ischemia and injury and is surprising...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.coph.2007.10.004

    authors: Simard JM,Woo SK,Bhatta S,Gerzanich V

    更新日期:2008-02-01 00:00:00

  • Monoclonal antibodies as a strategy for pulmonary diseases.

    abstract::Monoclonal antibodies have been used successfully to elucidate the roles of putative mediators of pulmonary disease. In particular, clinical trials with monoclonal antibodies directed against interleukin-5, IgE or CD4 yielded results that were critical in dissecting the pathophysiology of asthma; but, more importantly...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00047-9

    authors: Torphy TJ,Li L,Griswold DE

    更新日期:2001-06-01 00:00:00

  • Role of HMGB1 in cardiovascular diseases.

    abstract::A nuclear protein, high mobility group box 1 (HMGB1), is released passively by necrotic cells, and actively by macrophages/monocytes in response to exogenous and endogenous inflammatory stimuli. After binding to the receptor for advanced glycation end products (RAGE) or toll-like receptor 4 (TLR4), HMGB1 activates vas...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.10.010

    authors: Li W,Sama AE,Wang H

    更新日期:2006-04-01 00:00:00

  • The application of in vitro surveillance data for antibacterial dose selection.

    abstract::In vitro surveillance data, which provide key information to interpret the results of pharmacokinetic/pharmacodynamics (PK-PD) target attainment studies, are used to support dose selection decisions and recommendations for in vitro susceptibility testing criteria for antibacterial agents during drug development. Consi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.10.009

    authors: Flamm RK,Sader HS,Castanheira M,Jones RN

    更新日期:2017-10-01 00:00:00

  • Therapeutic opportunities in the B7/CD28 family of ligands and receptors.

    abstract::The CD28 and B7 protein families are critical regulators of immune responses and, in the past few years, several new family members have been identified. Preclinical studies exploring the role of members of the CD28 and B7 families support the targeting of these pathways for new therapeutic approaches. Indeed, recent ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.02.003

    authors: Carreno BM,Carter LL,Collins M

    更新日期:2005-08-01 00:00:00

  • Aptamers as candidate therapeutics for cardiovascular indications.

    abstract::The first therapeutic aptamer was approved for human use in 2004, and a range of chemical substitutions that improve the drug-like properties of aptamers has recently been shown to increase the utility of this modality. Currently there are both anticoagulant and antithrombotic aptamers in the clinic, and additionally ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.12.005

    authors: Keefe AD,Schaub RG

    更新日期:2008-04-01 00:00:00

  • Putative druggable targets for selective enhancement of cardiac conduction.

    abstract::Putative druggable targets to selectively enhance cardiac conduction can be considered from the level of the ion channels determining the initiation and duration of the cardiac action potential to the gap junction proteins responsible for optimal cellular electrical coupling. Nature has provided a number of inherited ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.coph.2008.11.008

    authors: Gomes J,Lambiase PD

    更新日期:2009-04-01 00:00:00

  • The abandonment of antibacterials: why and wherefore?

    abstract::The pharmaceutical industry is currently abandoning its antibacterial discovery research efforts. This seems to be part of a cyclical pattern in this therapeutic area. The reasons behind these ongoing cycles of feast and famine are multiple, but most revolve around the perception of market opportunities from the conti...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.04.003

    authors: Shlaes DM

    更新日期:2003-10-01 00:00:00

  • Oxidative stress-elicited myocardial apoptosis during reperfusion.

    abstract::Myocardial apoptosis primarily triggered during reperfusion has been associated with cardiac dysfunction and extension of infarction. Although potential signaling pathways involved in triggering apoptosis remain to be clearly defined, an increasing number of experiments have implicated the generation of reactive oxyge...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.10.010

    authors: Zhao ZQ

    更新日期:2004-04-01 00:00:00

  • Neurotrophic effects of antidepressant drugs.

    abstract::The past decade has witnessed a growing interest in the trophic effects of antidepressant drugs. Antidepressants stimulate the production and signaling of plasticity-related proteins such as neurotrophins and cAMP response element binding protein, and neurotrophin signaling appears to be both sufficient and necessary ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.10.004

    authors: Castrén E

    更新日期:2004-02-01 00:00:00

  • Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways.

    abstract::Synthetic glucocorticoids are potent modulators of the immune system, and are clinically invaluable in the treatment of a wide variety of conditions. However, their use can be limited by harmful side effects, and their mechanisms of action remain poorly understood and controversial. It has recently been reported that ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00073-0

    authors: Clark AR,Lasa M

    更新日期:2003-08-01 00:00:00

  • Promising pharmacologic innovations in treating pulmonary fibrosis.

    abstract::Idiopathic pulmonary fibrosis is the most common form of the interstitial lung diseases and is characterized by chronic progressive pulmonary parenchymal fibrosis. Although the diagnosis and pathophysiology of this disease have been better characterized over the past few years, there remains no effective therapy for t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.03.003

    authors: Bhatt N,Baran CP,Allen J,Magro C,Marsh CB

    更新日期:2006-06-01 00:00:00

  • The role of mitochondria in health and disease.

    abstract::Mitochondria play a key role in energy metabolism in many tissues, including skeletal muscle and liver. Inherent disorders of mitochondria such as DNA deletions cause major disruption of metabolism and can result in severe impairment or death. However, the occurrence of such disorders is extremely rare and cannot acco...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.09.002

    authors: Johannsen DL,Ravussin E

    更新日期:2009-12-01 00:00:00

  • Antibody therapy for rheumatoid arthritis.

    abstract::High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to protect joints from st...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00032-8

    authors: Taylor PC

    更新日期:2003-06-01 00:00:00

  • Thymic stromal lymphopoietin: a new cytokine in asthma.

    abstract::Airway epithelial cells provide mechanical and immune protection against pathogens and allergens. Following activation, these cells produce a wide range of cytokines including thymic stromal lymphopoietin (TSLP). Recently it was established that a high level of TSLP is associated with asthma in mice and in humans. The...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.03.002

    authors: Rochman Y,Leonard WJ

    更新日期:2008-06-01 00:00:00

  • Contributions of adipocyte lipid metabolism to body fat content and implications for the treatment of obesity.

    abstract::Obesity is a chronic disease that increases susceptibility to various diseases, particularly cardiovascular dysfunction, type 2 diabetes, and some types of cancer. In this review, we highlighted recent evidence in mouse models that support a potential benefit of increasing adipose lipid utilization through stimulating...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2010.05.008

    authors: Marcelin G,Chua S Jr

    更新日期:2010-10-01 00:00:00

  • P2X4 receptors, immunity, and sepsis.

    abstract::Sepsis is life-threatening systemic organ dysfunction caused by a deregulated host response to an infectious insult. Currently, the treatment of sepsis is limited to the use of antibiotics, fluids, and cardiovascular/respiratory support. Despite these interventions, septic mortality remains high, with reduced life qua...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.02.011

    authors: Antonioli L,Blandizzi C,Fornai M,Pacher P,Lee HT,Haskó G

    更新日期:2019-08-01 00:00:00

  • New approaches to targeting the bone marrow microenvironment in multiple myeloma.

    abstract::Multiple myeloma is a tumour with a remarkably destructive effect on its host organ, the bone marrow. Through expression or secretion of adhesion molecules, growth factors, exosomes, miRNAs, chemokines and inhibitors, the tumour substantially alters its microenvironment, promoting both tumour survival and osteolytic b...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.02.013

    authors: Gooding S,Edwards CM

    更新日期:2016-06-01 00:00:00

  • Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptors.

    abstract::Recent advances in the development of potent and selective peptide and non-peptide ligands for peptidergic receptors are anticipated to help further unravel the roles of class I and II G-protein-coupled receptors in the pathogenesis of human diseases and to accelerate the clinical utility of small molecule peptidomime...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.06.003

    authors: Jones RM,Boatman PD,Semple G,Shin YJ,Tamura SY

    更新日期:2003-10-01 00:00:00

  • Therapeutic potential of marine n-3 fatty acids in CABG patients.

    abstract::Dietary intake of marine n-3 polyunsaturated fatty acids (PUFA) has beneficial effects in various cardiac disorders. Few studies have, however, investigated the therapeutic potential of n-3 PUFA in patients undergoing coronary artery bypass grafting (CABG). Five heterogeneous randomized studies on n-3 PUFA for prevent...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.01.012

    authors: Andreasen JJ,Schmidt EB

    更新日期:2012-04-01 00:00:00

  • 2-5A antisense treatment of respiratory syncytial virus.

    abstract::Although a prominent cause of upper and lower respiratory tract disease in infants and the elderly, clinical options for treatment of respiratory syncytial virus (RSV) infections remain limited. Historically, attempts to develop vaccines have been unsuccessful, and rapid viral mutation rates have stifled development o...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.05.003

    authors: Leaman DW

    更新日期:2005-10-01 00:00:00

  • Cell death and cancer therapy.

    abstract::Successful cancer therapy requires the selective killing of cancer cells. Many molecular components of the pathways that lead to cell death have recently been identified and a number of these, including p53, Apaf-1, and members of the inhibitor of apoptosis protein and Bcl-2 gene families, have been found to be altere...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00059-5

    authors: Bunz F

    更新日期:2001-08-01 00:00:00

  • Purinergic signalling in the lung: important in asthma and COPD?

    abstract::During the past decade, evidence has accumulated for the involvement of purines and purine receptors in the pathogenesis and pathophysiology of asthma and chronic obstructive pulmonary diseases. In particular, the indirect bronchospasmic and inflammatory actions of purines via the activation and degranulation of mast ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2004.01.010

    authors: Adriaensen D,Timmermans JP

    更新日期:2004-06-01 00:00:00

  • OATP transporter-mediated drug absorption and interaction.

    abstract::Although oral administration of drugs is the most favorable route, the precise mechanism of intestinal epithelial permeation is not well understood. Recently, compelling evidence has emerged to show that absorptive transporters such as OATPs contribute to intestinal drug absorption. Since changes in intestinal transpo...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.09.001

    authors: Tamai I,Nakanishi T

    更新日期:2013-12-01 00:00:00

  • PET imaging: implications for the future of therapy monitoring with PET/CT in oncology.

    abstract::Among the methods based on molecular imaging, the measure of the tracer uptake variation between a baseline and follow-up scan with the SUV and [(18)F]FDG-PET/CT is a very powerful tool for assessing response to treatment in oncology. However, the development of new targeted therapeutics and tissue pharmacokinetic eva...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.07.016

    authors: Tomasi G,Rosso L

    更新日期:2012-10-01 00:00:00

  • Controlling ionotropic and metabotropic glutamate receptors with light: principles and potential.

    abstract::Light offers unique advantages for studying and manipulating biomolecules and the cellular processes that they control. Optical control of ionotropic and metabotropic glutamate receptors has garnered significant interest, since these receptors are central to signaling at neuronal synapses and only optical approaches p...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.12.008

    authors: Reiner A,Levitz J,Isacoff EY

    更新日期:2015-02-01 00:00:00